No Data
No Data
Catalyst Watch: Spotlight on Tesla, Alphabet Earnings, AACR Drug Data, and Global PMI Reports
AstraZeneca's (AZN.US) class 1 innovative drug for breast cancer has been approved in China.
The National Medical Products Administration of China (NMPA) has approved the launch of AstraZeneca's Class 1 Innovative Drug capivasertib.
SA Asks: What's the Best Weight-loss Drug Stock Right Now?
AstraZeneca Unit Faces US Class Action Lawsuit Alleging Misuse of Soliris Patent
Trump's New Order Targets Drug Pricing Transparency And Medicare Cost Reduction
Trump Targets Medicare Price Negotiations in New Executive Order